Sanofi

Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Flag link:
First Oral Drug for Type 1 Diabetes Could be Available in 2018
First Oral Drug for Type 1 Diabetes Could be Available in 2018
Xtalks
type 1 diabetes
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
Flag link:
EASD: Sanofi's Toujeo bests Lantus at holding off hypoglycemia, studies show
EASD: Sanofi's Toujeo bests Lantus at holding off hypoglycemia, studies show
Fierce Pharma
Sanofi
EASD
Toujeo
Lantus
hypoglycemia
diabetes
Flag link:
Sanofi indicates dupilumab could be used to treat nasal polyps
Sanofi indicates dupilumab could be used to treat nasal polyps
Yahoo/Reuters
Sanofi
dupilumab
Dupixent
nasal polyps
Flag link:
5 Things Regeneron's CEO Said as the Biotech Stock Sank
5 Things Regeneron's CEO Said as the Biotech Stock Sank
Motley Fool
Regeneron
Pharma CEOs
Leonard Schleifer
Sanofi
Dupixent
Flag link:
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GoInPharma
GSK
JNJ
Sanofi
Merck KGaA
consumer health
M&A
Flag link:
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
Xconomy
Regeneron
asthma
FDA
Sanofi
Dupixent
Flag link:
AbbVie preps JAK atopic dermatitis candidate for phase 3
AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
AbbVie
JAK inhibitors
clinical trials
atopic dermatitis
Upadacitinib
Sanofi
Regeneron
Dupixent
Flag link:
Sanofi, Regeneron earn ‘breakthrough’ status for a fast-track drug out to prove PD-1 dominance
Sanofi, Regeneron earn ‘breakthrough’ status for a fast-track drug out to prove PD-1 dominance
Endpoints
Sanofi
Regeneron
fast track
breakthrough status
cemiplimab
anti-PD-L1
Flag link:
Insurers, doctors battle over new heart disease drugs
Insurers, doctors battle over new heart disease drugs
CNBC
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Flag link:
Sanofi quietly pulls the plug on its Zika vaccine project
Sanofi quietly pulls the plug on its Zika vaccine project
Stat
Sanofi
Zika virus
vaccines
Flag link:
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract
Fierce Pharma
Sanofi
Zika virus
vaccines
R&D
government contracts
Flag link:
Sanofi wins tentative FDA nod for Admelog insulin lispro injection
Sanofi wins tentative FDA nod for Admelog insulin lispro injection
Drug Delivery Business News
Sanofi
FDA
Admelog insulin lispro
diabetes
Flag link:
Top 25 vaccine products in 2016, based on U.S. sales
Top 25 vaccine products in 2016, based on U.S. sales
Medical Marketing and Media
vaccines
Pfizer
Merck
Sanofi
Prevnar 13
Gardasil
Fluzone
Varivax
Menactra
Flag link:
Why Sanofi's dengue fever vaccine fell short of expectations
Why Sanofi's dengue fever vaccine fell short of expectations
Medical Marketing and Media
Sanofi
vaccines
dengue
Dengvaxia
Flag link:
In cost debate, Amgen stands by Repatha's value
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Flag link:
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
Fierce Pharma
Pfizer
Eucrisa
DTC
eczema
Dupixent
Sanofi
Regeneron
Flag link:
An analysis of 2017 first half for pharmaceutical industry
An analysis of 2017 first half for pharmaceutical industry
GoInPharma
pharma industry
Pfizer
Sanofi
GSK
Roche
Celgene
Bristol-Myers Squibb
Flag link:
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
Flag link:
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
Flag link: